INTEGRA LIFESCIENCES HOLDINGS CORP Proceeds from Collection of Notes Receivable
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Proceeds from Collection of Notes Receivable of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2022-02-24
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from collection of notes receivable for the quarter ending 2020-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from collection of notes receivable for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from collection of notes receivable for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from collection of notes receivable for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from collection of notes receivable for fiscal 2021 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from collection of notes receivable for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from collection of notes receivable for fiscal 2019 was $752.00K, a 17.36% decline from fiscal 2018.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from collection of notes receivable for fiscal 2018 was $910.00K, a 88.41% increase from fiscal 2017.
| Period end | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month | Proceeds from Collection of Notes Receivable 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $257.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $257.00K derived: sum of 3 quarters · filed 2022-02-24 | $507.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $257.00K derived: sum of 2 quarters · filed 2022-02-24 | $507.00K derived: sum of 3 quarters · filed 2022-02-24 | $752.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $257.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $507.00K derived: sum of 2 quarters · filed 2020-10-29 | $752.00K 10-Q · filed 2020-10-29 | $983.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $495.00K 10-Q · filed 2020-08-10 | $726.00K derived: sum of 3 quarters · filed 2021-02-23 | $959.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $245.00K 10-Q · filed 2020-05-07 | $476.00K derived: sum of 2 quarters · filed 2021-02-23 | $709.00K derived: sum of 3 quarters · filed 2021-02-23 | $934.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $464.00K derived: sum of 2 quarters · filed 2021-02-23 | $689.00K derived: sum of 3 quarters · filed 2021-02-23 | $910.00K 10-K · filed 2021-02-23 |
| 2018-09-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $458.00K derived: sum of 2 quarters · filed 2019-10-25 | $679.00K 10-Q · filed 2019-10-25 | $679.00K derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $446.00K 10-Q · filed 2019-07-25 | $446.00K derived: sum of 3 quarters · filed 2020-02-21 | $929.00K derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $221.00K 10-Q · filed 2019-04-29 | $221.00K derived: sum of 2 quarters · filed 2020-02-21 | $704.00K derived: sum of 3 quarters · filed 2020-02-21 | $704.00K derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $483.00K derived: sum of 2 quarters · filed 2020-02-21 | $483.00K derived: sum of 3 quarters · filed 2020-02-21 | $483.00K 10-K · filed 2020-02-21 |
| 2017-09-30 | $483.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $483.00K derived: sum of 2 quarters · filed 2018-11-01 | $483.00K 10-Q · filed 2018-11-01 | $483.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $0.00 10-Q · filed 2018-07-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-04-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-10-26 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |